APA (7th ed.) Citation

Williams, T. M., Schneeweiss, A., Jackisch, C., Shen, C., Weber, K. E., Fasching, P. A., . . . Loibl, S. (2023). Caveolin gene expression predicts clinical outcomes for early-stage HER2-negative breast cancer treated with paclitaxel-based chemotherapy in the GeparSepto trial. Clinical cancer research, 29(17), . https://doi.org/10.1158/1078-0432.CCR-23-0362

Chicago Style (17th ed.) Citation

Williams, Terence M., et al. "Caveolin Gene Expression Predicts Clinical Outcomes for Early-stage HER2-negative Breast Cancer Treated with Paclitaxel-based Chemotherapy in the GeparSepto Trial." Clinical Cancer Research 29, no. 17 (2023). https://doi.org/10.1158/1078-0432.CCR-23-0362.

MLA (9th ed.) Citation

Williams, Terence M., et al. "Caveolin Gene Expression Predicts Clinical Outcomes for Early-stage HER2-negative Breast Cancer Treated with Paclitaxel-based Chemotherapy in the GeparSepto Trial." Clinical Cancer Research, vol. 29, no. 17, 2023, https://doi.org/10.1158/1078-0432.CCR-23-0362.